Global Standards Confusion

WHO’s role in establishing health standards may weaken without American expertise and harmonization efforts. Regulatory alignment across countries could fragment, creating market uncertainty for medications and medical devices. Pharmaceutical companies worry about contradictory guidelines emerging in different regions of the world. Discussions about new international standards stalled throughout 2025 due to this uncertainty. Product approvals could require separate processes for each market. The medical innovation pipeline becomes more complicated.